title: Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras.
abstract: The pathways by which mammalian Ras proteins induce cortical actin rearrangement and cause cellular transformation are investigated using partial loss of function mutants of Ras and activated and inhibitory forms of various postulated target enzymes for Ras. Efficient transformation by Ras requires activation of other direct effectors in addition to the MAP kinase kinase kinase Raf and is inhibited by inactivation of the PI 3-kinase pathway. Actin rearrangement correlates with the ability of Ras mutants to activate PI 3-kinase. Inhibition of PI 3-kinase activity blocks Ras induction of membrane ruffling, while activated PI 3-kinase is sufficient to induce membrane ruffling, acting through Rac. The ability of activated Ras to stimulate PI 3-kinase in addition to Raf is therefore important in Ras transformation of mammalian cells and essential in Ras-induced cytoskeletal reorganization.
authors.affiliation: Imperial Cancer Research Fund, London, United Kingdom.
authors.forename: P
authors.initials: P
authors.lastname: Rodriguez-Viciana
authors.forename: P H
authors.initials: PH
authors.lastname: Warne
authors.forename: A
authors.initials: A
authors.lastname: Khwaja
authors.forename: B M
authors.initials: BM
authors.lastname: Marte
authors.forename: D
authors.initials: D
authors.lastname: Pappin
authors.forename: P
authors.initials: P
authors.lastname: Das
authors.forename: M D
authors.initials: MD
authors.lastname: Waterfield
authors.forename: A
authors.initials: A
authors.lastname: Ridley
authors.forename: J
authors.initials: J
authors.lastname: Downward
mesh_terms: D016475:3T3 Cells / Q000737:chemistry / Q000166:cytology / Q000201:enzymology; D000199:Actins / Q000378:metabolism*; D000818:Animals; D001011:Aorta / Q000166:cytology; D019556:COS Cells / Q000737:chemistry / Q000166:cytology / Q000201:enzymology; D002462:Cell Membrane / Q000502:physiology; D048429:Cell Size / Q000502:physiology; D002867:Chromones / Q000494:pharmacology; D003599:Cytoskeleton / Q000378:metabolism*; D004730:Endothelium, Vascular / Q000166:cytology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D051379:Mice; D009025:Morpholines / Q000494:pharmacology; D009154:Mutation / Q000502:physiology; D009281:Naphthalenes / Q000494:pharmacology; D019869:Phosphatidylinositol 3-Kinases; D018129:Phosphatidylinositol Phosphates / Q000378:metabolism; D017853:Phosphotransferases (Alcohol Group Acceptor) / Q000502:physiology*; D010982:Platelet-Derived Growth Factor / Q000378:metabolism; D011493:Protein Kinase C / Q000037:antagonists & inhibitors; D013552:Swine; D014170:Transformation, Genetic / Q000187:drug effects / Q000502:physiology*; D018631:ras Proteins / Q000235:genetics / Q000378:metabolism*
chemical_list: D000199:Actins; D002867:Chromones; D004791:Enzyme Inhibitors; D009025:Morpholines; D009281:Naphthalenes; D018129:Phosphatidylinositol Phosphates; D010982:Platelet-Derived Growth Factor; C060974:phosphatidylinositol 3,4,5-triphosphate; C085911:2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one; D019869:Phosphatidylinositol 3-Kinases; D017853:Phosphotransferases (Alcohol Group Acceptor); D011493:Protein Kinase C; D018631:ras Proteins; C058819:calphostin C